316 related articles for article (PubMed ID: 18371180)
61. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
[TBL] [Abstract][Full Text] [Related]
62. New developments and controversies in the neuropathology of malignant gliomas.
Wiestler OD; Schmidt MC; von Deimling A; Reifenberger G; Deckert-Schlüter M; Radner H; Pietsch T
Front Radiat Ther Oncol; 1999; 33():123-38. PubMed ID: 10549483
[No Abstract] [Full Text] [Related]
63. [Schmidt Ruppin-D-ASV-induced primary rat brain tumor model for therapeutic screening].
Nakamura O; Hojo S; Takakura K; Nagashima K; Ishizaki R
No To Shinkei; 1982 Jul; 34(7):691-7. PubMed ID: 6291561
[TBL] [Abstract][Full Text] [Related]
64. Computerized classification of gliomas by automated microscope picture analysis (AMPA).
Martin H; Voss K
Acta Neuropathol; 1982; 58(4):261-8. PubMed ID: 6297226
[No Abstract] [Full Text] [Related]
65. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
Schwartz SA; Weil RJ; Thompson RC; Shyr Y; Moore JH; Toms SA; Johnson MD; Caprioli RM
Cancer Res; 2005 Sep; 65(17):7674-81. PubMed ID: 16140934
[TBL] [Abstract][Full Text] [Related]
66. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
67. WHO 2016 Classification of gliomas.
Wesseling P; Capper D
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
[TBL] [Abstract][Full Text] [Related]
68. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.
Delgado-López PD; Corrales-García EM; Martino J; Lastra-Aras E; Dueñas-Polo MT
Clin Transl Oncol; 2017 Aug; 19(8):931-944. PubMed ID: 28255650
[TBL] [Abstract][Full Text] [Related]
69. Radiation-induced gliomas: a report of four cases and analysis of molecular biomarkers.
Nakao T; Sasagawa Y; Nobusawa S; Takabatake Y; Sabit H; Kinoshita M; Miyashita K; Hayashi Y; Yokoo H; Nakada M
Brain Tumor Pathol; 2017 Oct; 34(4):149-154. PubMed ID: 28795231
[TBL] [Abstract][Full Text] [Related]
70. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
[TBL] [Abstract][Full Text] [Related]
71. Low-grade gliomas.
Schiff D
J Neurosurg; 2011 Nov; 115(5):945-7; author reply 947. PubMed ID: 21854121
[No Abstract] [Full Text] [Related]
72. Histopathology, classification, and grading of gliomas.
Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
[TBL] [Abstract][Full Text] [Related]
73. Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas.
Mason WP; Cairncross JG
Neurology; 2008 Jul; 71(5):365-73. PubMed ID: 18663182
[TBL] [Abstract][Full Text] [Related]
74. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets.
Fuller GN; Hess KR; Rhee CH; Yung WK; Sawaya RA; Bruner JM; Zhang W
Brain Pathol; 2002 Jan; 12(1):108-16. PubMed ID: 11771519
[TBL] [Abstract][Full Text] [Related]
75. Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.
Bai J; Varghese J; Jain R
Top Magn Reson Imaging; 2020 Apr; 29(2):71-82. PubMed ID: 32271284
[TBL] [Abstract][Full Text] [Related]
76. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
77. Brain stem gliomas: a classification system based on magnetic resonance imaging.
Barkovich AJ; Krischer J; Kun LE; Packer R; Zimmerman RA; Freeman CR; Wara WM; Albright L; Allen JC; Hoffman HJ
Pediatr Neurosurg; 1990-1991; 16(2):73-83. PubMed ID: 2132928
[TBL] [Abstract][Full Text] [Related]
78. Fall of the Optical Wall: Freedom from the Tyranny of the Microscope Improves Glioma Risk Stratification.
Ramaswamy V; Taylor MD
Cancer Cell; 2016 Feb; 29(2):137-8. PubMed ID: 26859451
[TBL] [Abstract][Full Text] [Related]
79. Differentiating Nonenhancing Grade II Gliomas from Grade III Gliomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
Alkanhal H; Das K; Rathi N; Syed K; Poptani H
World Neurosurg; 2021 Feb; 146():e555-e564. PubMed ID: 33152494
[TBL] [Abstract][Full Text] [Related]
80. Radiation-induced gliomas.
Prasad G; Haas-Kogan DA
Expert Rev Neurother; 2009 Oct; 9(10):1511-7. PubMed ID: 19831840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
